Uvavanyo oluKhawulezayo lwe-EZER Flu&COVID-19 Antigen Combo
Intshayelelo
Intsholongwane yoMkhuhlane yeyosapho lweOrthomyxoviridae, kunye neentsholongwane zeRNA ezinomsonto omnye.Kukho intsholongwane yomkhuhlane A kunye no-B yeyona pathogen iphambili kwizigulo eziqatha ebantwini nakwiintlobo ezininzi zezilwanyana.Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela liyi-1 ukuya kwiintsuku ezi-4.Izibonakaliso eziphambili ziquka umkhuhlane obukhali, ubuhlungu obuqhelekileyo kunye neempawu zokuphefumla.Zombini iintsholongwane zohlobo A no-B zinokujikeleza ngaxeshanye, kodwa ngokuqhelekileyo uhlobo olunye lulawula ngexesha lonyaka elinikiweyo.
I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla.Ngokuqhelekileyo abantu basengozini.Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo;abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo.Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7.Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo.Ukuxinana kweempumlo, impumlo evuzayo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.
Iimpawu zeklinikhi kunye neempawu zosulelo lwentsholongwane yokuphefumla ngenxa ye-SARS-CoV-2 kunye nomkhuhlane zinokufana.I-SARS-CoV-2, umkhuhlane A kunye ne-antigens yentsholongwane yomkhuhlane B zibonwa ngokubanzi kwisampulu yokuphefumla ephezulu ngexesha lenqanaba elibukhali losulelo.
I-EZERTMUvavanyo olukhawulezileyo lwe-Flu&COVID-19 Antigen Combo Rapid lubandakanya uvavanyo olukhawulezileyo lwe-antigen yomkhuhlane kunye novavanyo olukhawulezayo lwe-antigen ye-COVID-19, luvavanyo lwe-immunochromatographic lokubona umgangatho weNoveli yeCoronavirus ka-2019, umkhuhlane A kunye nee-antigens ze-B.I-EZERTMUvavanyo oluKhawulezayo lwe-Flu&COVID-19 Antigen Combo Rapid lunoonobumba abane kumphezulu wemigca ebonisa umgca wovavanyo (S)﹑ (A)﹑ (B) kunye nomgca wolawulo (C).
Ukufunyanwa
I-EZERTMUvavanyo oluKhawulezayo lwe-Flu&COVID-19 Antigen Combo Rapid lwenzelwe ukufunyaniswa komgangatho ngaxeshanye kunye nokwahlulwa kwe-nucleocapsid protein antigens ukusuka kwi-SARS-CoV-2, umkhuhlane A kunye nomkhuhlane B kwimizekelo ethe ngqo yeempumlo.
Umzekelo
Ngempumlo
Umda wokuFumana (LoD)
Umkhuhlane&COVID-19:140 TCID50/mL
Ubuncinci bomda wokubhaqwa koMkhuhlane we-EZERTMUvavanyo olukhawulezayo lwe-Flu&COVID-19 Antigen Combo Rapid yasekwa ngokusekwe kumkhuhlane osi-8 uwonke.
| Uxinzelelo lweNtsholongwane yoMkhuhlane | I-LoD ebaliwe |
| A/New Caledonia/20/1999_H1N1 | 8.50x103 |
| A/California/04/2009_H1N1 | 2.11x103 |
| A/PR/8/34_H1N1 | 2.93x103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
| A/Guizhou/54/89_H3N2 | 3.95x102 |
| A/Human/Hubei/3/2005_H3N2 | 2.93x104 |
| A/Bar-headed Goose/QH/BTY2/2015_H5N1 | 1.98x105 |
| A/Anhui/1/2013_H7N9 | 7.90x105 |
Umkhuhlane B ubuncinci bomda wokuchongwa we EZERTMUvavanyo olukhawulezileyo lwe-Flu&COVID-19 Antigen Combo Rapid yasekwa ngokusekwe kumkhuhlane o-2 uwonke.
| Uxinzelelo lweNtsholongwane yoMkhuhlane | I-LoD ebaliwe |
| B/Victoria | 4.25x103 |
| B/Yamagata | 1.58x102 |
Ukuchaneka
|
| Umkhuhlane A | Umkhuhlane B | I-COVID-19 |
| Uvakalelo olunxulumeneyo | 86.8% | 91.7% | 96.6% |
| Inkcazelo ngokuthe ngqo | 94.0% | 97.5% | 100% |
| Ukuchaneka | 92.2% | 96.1% | 98.9% |
Ixesha leziphumo
Funda iziphumo ngemizuzu eyi-15 kwaye ungabi ngaphezu kwemizuzu engama-30.
Iimeko zokugcina iikhithi
2–30°C
Imixholo
| Inkcazo | Qty |
| Izixhobo zovavanyo | 20 |
| Iiswabs ezisterilized | 20 |
| Imibhobho yokukhupha | 20 |
| Imilomo | 20 |
| Ukuma kwetyhubhu | 1 |
| Faka iphakheji | 1 |
Ukuodola Ulwazi
| Imveliso | Ikati.No. | Imixholo |
| I-EZERTMUmkhuhlane & COVID-19 Antigen Combo | P213110 | Iimvavanyo ezingama-20 |
